Professional Documents
Culture Documents
Regulation of Body Weight
Regulation of Body Weight
WEIGHT
THE BIOCHEMISTRY OF APPETITE AND
ENERGY EXPENDITURE
REGULATION OF BODY WEIGHT
OVERVIEW
ORGAN SPECIALIZATION
METABOLIC PATHWAYS
HOMEOSTASIS
PROTEINS INVOLVED IN WEIGHT REGULATION
DYSREGULATION
STARVATION
OBESITY
DIABETES: TYPES I AND II
DIETING
ATKINS DIET
OVERVIEW 1
NORMAL METABOLISM IS A HIGHLY CONTROLLED AND REGULATED
BALANCE BETWEEN ANABOLISM AND CATABOLISM
GLYCOLYTIC/GLUCONEOGENIC
GLYCOGEN METABOLISM
FATTY ACID METABOLISM
CITRIC ACID CYCLE
AMINO ACID METABOLISM
PENTOSE PHOSPHATE PATHWAY
OXIDATIVE PHOSPHORYLATION
OVERVIEW 3 : COMPARTMENTALIZATION
TWO COMPARTMENTS IN WHICH METABOLISM IS
DIVIDED:
CYTOSOL
GLYCOLYSIS
GLUCONEOGENESIS
GLYCOGEN BREAKDOWN AND SYNTHESIS
PENTOSE PHOSPHATE PATHWAY
FATTY ACID SYNTHESIS
AMINO ACID DEGRADATION AND UREA CYCLE
MITOCHONDRIA
CITRIC ACID CYCLE
OXIDATIVE PHOSPHORYLATION
FATTY ACID OXIDATION
AMINO ACID DEGRADATION AND UREA CYCLE
MEMBRANE TRANSPORT BETWEEN CYTOSOL AND
MITOCHONDRIA
OVERVIEW 4
MITOCHONDRIAL-CYTOSOLIC INTERFACE
PYRUVATE TRANSPORTER
CARNITINE/ACYLCARNITINE TRANSPORTER
CITRATE TRANSPORTER
ASPARTATE TRANSPORTER
MALATE TRANSPORTER
CITRULLINE TRANSPORTER
ORNITHINE TRANSPORTER
OTHERS
OVERVIEW 5
ORGANS ARE SPECIALIZED WITH REGARD TO
METABOLISM
DIFFERENT METABOLIC NEEDS AND FUNCTIONS
INTER-ORGAN COORDINATION
BRAIN
MUSCLE (SKELETAL AND HEART)
LIVER
KIDNEY
ADIPOSE TISSUE
ORGAN SPECIALIZATION: MUSCLE
MUSCLE FUELS:
GLUCOSE
FROM GLYCOGEN
FATTY ACIDS
KETONE BODIES
GLYCOGEN
GLYCOGEN GLUCOSE-6-PHOSPHATE
ATP RESUPPLY
INITIALLY FROM PHOSPHOCREATINE (1st 4s OF MAX. EXERTION)
PHOSPHOCREATINE + ADP CREATINE + ATP
RESPIRATION (GLYCOLYSIS OF G-6-P)
ANAEROBIC DEGRADATION TO LACTATE
WHEN GLYCOLYTIC FLUX > KREBS, OXPHOS FLUXES
MUSCLE
LACTATE
pH MUSCLE FATIGUE
TRANSFERRED TO LIVER VIA BLOOD
HEART MUSCLE
AEROBIC
PRIMARILY FATTY ACIDS AS FUEL
CAN ALSO USE
GLUCOSE (FROM SMALL GLYCOGEN STORE)
KETONE BODIES
PYRUVATE, LACTATE
MUSCLE
CARBOHYDRATE METABOLISM IN MUSCLE SOLELY
SERVES MUSCLE
IN STARVATION
PROTEOLYTIC DEGRADATION OF MUSCLE TO
AMINO ACIDS
MUSCLE METABOLISM
TO LIVER
TO LIVER
ALANINE
LACTATE
INTO
AMINO ACIDS PYRUVATE H2O + CO2 BLOOD
PROTEINS
GLUCOSE
GLYCOGEN FATTY ACIDS
+
FROM LIVER
KETONE BODIES
INTERORGAN PATHWAYS
IN-CLASS EXERCISE ***
+
TRIACYLGLYCEROLS
WELL-FED GLYCEROL
WELL-FED STATE
KETONE BODIES
TO BLOOD
GLUCOSE
LIVER
A “CENTRAL CLEARINGHOUSE” FOR METABOLITES
ALL NUTRIENTS ABSORBED BY INTESTINES DRAIN
DIRECTLY INTO THE LIVER VIA THE PORTAL VEIN
EXCEPT FATTY ACIDS
REGULATES BLOOD GLUCOSE LEVEL
RESPONDS TO:
INSULIN
GLUCAGON
EPINEPHRINE
BLOOD GLUCOSE LEVEL
LIVER
WHAT HAPPENS AFTER CHO INGESTION?
LIVER CELLS ARE PERMEABLE TO GLUCOSE
INSULIN HAS NO DIRECT EFFECT ON UPTAKE
WHEN [GLUCOSE] ~ 6 mM LIVER CONVERTS IT
TO G-6-P
GLUCOKINASE IS THE ENZYME
AN ISOZYME OF HEXOKINASE
REVIEW ENZYME KINETICS OF BOTH
KM = 0.1 mM FOR HEXOKINASE; 5 mM FOR GLUCOKINASE
HYPERBOLIC VS SIGMOIDAL KINETICS
LIVER
EARLY SATURATION OF HEXOKINASE
INHIBITION BY G-6-P
GLUCOKINASE ACTIVITY LINEAR AT
HIGHER [GLUCOSE]
NOT INHIBITED BY G-6-P
GLUCOKINASE IS MONOMERIC
ALLOSTERISM DOESN’T EXPLAIN KINETICS
OTHER ABSORBED SUGARS G-6-P IN
LIVER
CENTRAL ROLE OF GLUCOSE-6-
PHOSPHATE IN CHO METABOLISM
ITS FATE DEPENDS ON DEMAND FOR GLUCOSE
G6P GLUCOSE (G-6-PHOSPHATASE)
WHEN BLOOD [GLUCOSE] < 5 mM
TRANSPORT TO PERIPHERAL ORGANS
G6P GLYCOGEN
WHEN GLUCOSE DEMAND IS LOW
WHEN GLUCAGON AND/OR EPINEPHRINE LEVELS
INDICATES GLUCOSE DEMAND
GLYCOGEN G-6-P GLUCOSE
G-6-P PYRUVATE (GLYCOLYSIS) ACETYL CoA
OXIDIZED BY C.A. CYCLE AND OXPHOS OR
USED FOR FATTY ACID SYNTHESIS
ALSO PHOSPHOLIPIDS, CHOLESTEROL
PYRUVATE DEHYDROGENASE
G-6-P HEXOSE-MONOPHOSPHATE SHUNT
INTERORGAN PATHWAYS
IN-CLASS STUDY QUESTION ***
AMINO ACIDS CAN BE TRANSAMINATED TO ALANINE IN
MUSCLE BY USING PYRUVATE AS THE -KETOACID
SUBSTRATE. ALANINE IS RELEASED INTO THE
BLOODSTREAM AND CIRCULATES TO THE LIVER.
*NOTE: THE PHLEBOTOMIST WAS INSTRUCTED TO TRANSPORT THE LACTATE AND PYRUVATE
IMMEDIATELY TO THE LAB ON ICE.
CLINICAL CASE STUDY: CONTINUED
THE REMAINDER OF THE BLOOD STUDIES WERE NORMAL. AFTER THE
LABS RETURN, A FIBROBLAST CULTURE IS OBTAINED AND A PYRUVATE
CARBOXYLASE DEFICIENCY IS DIAGNOSED.
QUESTIONS:
EXPLAIN THE BIOCHEMICAL BASIS FOR EACH OF THE ABNORMAL LAB FINDINGS
IF THIS INFANT HAD NOT DIED, WHAT WOULD HAVE BEEN SOME POTENTIAL TREATMENTS?
HORMONAL INFLUENCES ON
METABOLISM
EPINEPHRINE
CYCLIC AMP AS SECONDARY MESSENGER
GLUCAGON
CYCLIC AMP AS SECONDARY MESSENGER
INSULIN
ACTIONS OF EPINEPHRINE
AS AN INSULIN ANTAGONIST
ACTIVATES MUSCLE GLYCOGEN PHOSPHORYLASE
GLUCOSE-6-P USED IN GLYCOLYSIS
L B
I I
RECEPTOR P L
I A
DY
ADENYLATE E
CYCLASE
R
GDP
GTP INTRACELLULAR
RECEPTOR
ADENYLATE
CYCLASE
GTP
GDP
RECEPTOR
ADENYLATE
CYCLASE
GTP
RECEPTOR
ADENYLATE
CYCLASE
GDP
+ PPi
PHOSPHOENOLPYRUVATE
ADP
CO2 + GDP PYRUVATE
KINASE
PEP CARBOXYKINASE
HYPOTHALAMUS
ARCUATE NUCLEUS
INSULIN OR
GHRELIN
LEPTIN
RECEPTOR -
RECEPTOR
OTHER
+ NEURONS
GHRELIN MSH
- NPY/ POMC/ RECEPTOR
AgRP CART
PYY3-36 - +
Y2R
(AN NPY RECEPTOR LEPTIN AND INSULIN
SUBTYPE)
LEPTIN
A MONOMERIC PROTEIN OF 146 RESIDUES
DISCOVERED IN 1994
EXPRESSED ONLY BY FAT CELLS
LEPTIN
GHRELIN
INSULIN
PYY3-36
APPETITE CONTROL AT HYPOTHALAMIC
LEVEL: SUMMARY (3)
LEPTIN AND INSULIN:
(1) STIMULATE POMC/CART NEURONS CART AND -MSH
LEVELS
(2) INHIBIT NPY/AgRP NEURONS NPY AND AgRP
http://nhlbisupport.com/bmi/
OBESITY
MAJOR FACTORS DRIVING THE OBESITY EPIDEMIC:
THE PHYSICAL ENVIRONMENT!
OVERCONSUMPTION
EASY AVAILABILITY OF FOODS
ENERGY-DENSE
LARGE PORTIONS
DECREASING FREQUENCY OF FAMILY MEALS
FAST FOOD RESTAURANTS
ADVERTISING TO CHILDREN
REDUCED PHYSICAL ACTIVITY
IN JOBS REQUIRING PHYSICAL ACTIVITY
GENERAL CONVENIENCES ENERGY EXPENDITURES
SEDENTARY ACTIVITIES
TV, VIDEO GAMES, WWW
OBESITY
FACTORS DRIVING INCREASE IN OBESITY:
THE SOCIAL ENVIRONMENT
TECHNOLOGY PRODUCTIVITY
FASTER PACE OF LIFE
INCREASED STRESS
NOT ENOUGH TIME
WALLMARTS : GETTING MORE FOR LESS
CHANGING FAMILY STRUCTURE
INCREASE IN BOTH PARENTS WORKING
INCREASE IN SINGLE-PARENT FAMILIES
SOCIAL ENVIRONMENT PHYS. ENVT.
RECIPROCITY
OBESITY
BIOLOGICAL FACTORS INVOLVED IN OBESITY
INDIVIDUAL DIFFERENCES IN HEIGHT, WEIGHT
FATS
HIGH SATIETY FACTOR
INGESTED FAT IS NOT STORED (LOW INSULIN)
EXCESS FAT IS CATABOLIZED AND EXCRETED
ATKINS DIET: STUDY QUESTIONS ***
EXPLAIN WHAT HAPPENS TO THE ACTIVITY OF THE
CITRIC ACID CYCLE WHEN SOMEONE IS ON THE
ATKINS DIET.
SYMPTOMS OF KETOSIS:
ABDOMINAL: PAIN, NAUSEA, VOMITING (DEHYDRATION), LIVER
FUNCTION ABNORMALITIES
NEUROLOGIC: FATIGUE, HEADACHE
METABOLIC: K+ LOSS, Ca++ LOSS, RTA
HEMATOLOGIC: HEMOLYTIC ANEMIA
CARDIAC: CARDIOMYOPATHY (POSSIBLY REVERSIBLE)
BIOCHEMISTRY OF THE ATKINS DIET
ACID-BASE EFFECTS:
KETONE BODIES BLOOD pH
A LOW pH GFR
RENAL TUBULAR REABSORPTION OF Ca++
CALCIUM IN URINE
Ca++ SALTS MOBILIZED FROM BONE
PO42- NEEDED TO BUFFER ACID LOAD TO KIDNEY
OSTEOPOROSIS
CALCIURIA STONE FORMATION
BIOCHEMISTRY OF ATKINS DIET
ADVANTAGES
IT WORKS IN THE SHORT RUN
TG AND HDL CHOLESTEROL LEVELS IMPROVED
RISK/BENEFIT ANALYSIS:
PROBABLY NOT FAVORABLE
WEIGHT LOSS NOT SUSTAINED (UNLESS YOU
STAY ON THE DIET)
IT’S UNHEALTHY
CAN RESULT IN SIGNIFICANT MORBIDITY
CAN RESULT IN PREMATURE DEATH
BIOCHEMISTRY OF THE ATKINS DIET
DESPITE ALL OF THE FANCY BIOCHEMISTRY, THE
BOTTOM LINE IS THAT INCREASED FAT IN THE DIET
CAUSES EARLY AND SUSTAINED SATIETY, WHICH
ULTIMATELY RESULTS IN LESS DAILY INTAKE OF
CALORIES. IT’S STILL A CONSEQUENCE OF THE
“FIRST LAW OF THERMODYNAMICS” (ENERGY IN –
ENERGY OUT).
THERE ARE NO SAFE FAD DIETS THAT BOTH WORK
AND ARE HEALTHY AT THE SAME TIME.
YOU WILL ALWAYS GAIN THE WEIGHT BACK
AFTER YOU STOP THE DIET.
A CLINICAL CASE STUDY
A 20 YEAR OLD, 5’ 4”, 180# FEMALE COLLEGE STUDENT WHO
HAS BEEN OVERWEIGHT SINCE THE AGE OF 3 YEARS VISITS
THE INFIRMARY BECAUSE SHE HASN’T BEEN FEELING WELL
LATELY. SHE HAS BEEN HAVING HEADACHES AND
CONSTIPATION FOR A FEW MONTHS AND SOMETIMES SHE
DOESN’T THINK AS CLEARLY AS SHE USED TO. HER PERIODS
HAVE BECOME IRREGULAR AND NOW SHE HAS ABDOMINAL
PAIN, BACK PAIN AND RED URINE. HER FRIENDS HAVE TOLD
HER THAT HER BREATH SMELLS “FUNNY”.
GLUT1 : ERYTHROCYTES
GLUT2 : PANCREATIC β-CELLS AND LIVER
CELLS
GLUT3 : BRAIN, PLACENTA, FETAL
MUSCLE
INSULIN ACTIONS AS A NEURAL SIGNAL
INSULIN RECEPTORS IN HYPOTHALAMUS
NEURONAL REGULATION OF
FOOD INTAKE (INCREASES APPETITE)
BODY WEIGHT
ACTIONS MEDIATED BY INSULIN
SIGNALING SYSTEM
SIGNAL TRANSDUCTION
REQUIRES BINDING OF INSULIN TO INSULIN
RECEPTORS
INSULIN
PROINSULIN INSULIN + C-PEPTIDE
SITE SPECIFIC CLEAVAGE AT THE SEQUENCES:
ARG-ARG
LYS-ARG
BOTH ARE COMMON SIGNALS FOR PROTEOLYTIC PROCESSING
2 INSULIN MONOMERS DIMERIZE
ANTIPARALLEL -SHEET ASSOCIATION
C-TERMINAL OF B-CHAIN
3 INSULIN DIMERS HEXAMER
ASSOCIATION REQUIRES Zn2+
Zn2+ RELEASED WHEN INSULIN SECRETED
HEXAMERS ARE STORED IN CELLS OF PANCREAS
RECOMBINANT SYNTHESIS OF INSULIN ANALOGS
“LISPRO” INSULIN: USUAL INSULIN OF CHOICE IN DIABETICS
PRO28 AND LYS29 ON B-CHAIN ARE SWITCHED
INSULIN MONOMERS DO NOT DIMERIZE
FASTER ONSET OF BIOLOGICAL ACTIVITY (15 MINUTES AFTER SC ADMIN.)
C-PEPTIDE: NO BIOLOGIC FUNCTION
PROTEINS: INSULIN IN PERIPHERAL
TISSUES
INSULIN HAS 2 CHAINS LINKED BY 2 DISULFIDE BRIDGES
THE “A” CHAIN: 21 AMINO ACIDS
THE “B” CHAIN: 30 AMINO ACIDS
GENE PRODUCT IS “PREPROINSULIN”
GENE IS ON SHORT ARM OF CHROMOSOME #11
AFTER TRANSLOCATION TO THE E.R. 23 N-TERMINAL
AMINO ACIDS ARE REMOVED “PROINSULIN”
PROINSULIN: CHAINS “A” AND “B” , 3 –S-S- BONDS, AND
“C” PEPTIDE
SINGLE CHAIN OF 86 AMINO ACIDS
PROINSULIN PACKAGED IN SECRETORY GRANULES
THE INSULIN RECEPTOR
A RECEPTOR TYROSINE KINASE
A TRANSMEMBRANE GLYCOPROTEIN
HAS A CYTOPLASMIC PTK DOMAIN
A PERMANENT DIMER (2 AND 2
SUBUNITS)
2 s ARE LINKED BY DISULFIDE BOND
EACH LINKED TO A BY –S-S- BOND
THE INSULIN RECEPTOR
WHEN INSULIN BINDS TO InsR,
CONFORMATIONAL CHANGE OCCURS
PTK DOMAINS FACE EACH OTHER
CROSS PHOSPHORLYATION
3 SPECIFIC TYR RESIDUES ARE PHOSPHORYLATED
“AUTOPHOSPHORYLATION”
ACTIVATED TYRs CAN FURTHER PHOSPHORYLATE AT:
OTHER TYRs OUTSIDE OF PTK DOMAIN
CYTOPLASMIC PROTEIN
INSULIN
S-S
S-S S-S
S-S
TRANSMEMBRANE PART
OF -SUBUNITS
MEMBRANE
Y1158 P Y
PTK DOMAIN
HAS Y-KINASE ACTIVITY
P Y1162 P Y
IRS-1 Y1163 P Y
INSULIN RECEPTOR SUBSTRATE-1 ACTIVATION
LOOP
INSULIN SIGNALING SYSTEM (1)
INSULIN BINDS TO THE INSULIN RECEPTOR
AUTOPHOSPHORYLATION AT TYR RESIDUES
-SUBUNITS OF IR
PROTEINS BOUND AND TYR-PHOSPHORYLATED BY THESE
phosTYRs
Shc
phosShc STIMULATES MAPK
Gab-1
phosGab-1 ACTIVATES MAPK ALSO
APS/Cbl Complex
phosAPS/Cbl STIMULATES TC10 (A G-PROTEIN)
ALSO REGULATES GLUCOSE TRANSPORT INDEPENDENT OF PI3K
INVOLVES LIPID RAFTS AND CAVEOLAE
IRS Proteins
phosIRS ACTIVATES PHOSPHOINOSITIDE CASCADE
PI3K INTERMEDIATE
STIMULATES: GLYCOGEN SYNTHESIS, GLUCOSE TRANSPORT,
CELL GROWTH AND DIFFERENTIATION
INSULIN SIGNALING SYSTEM (2)
OTHER CASCADES ACTIVATED:
MAPK (PHOSPHORYLATION)
PI3K (PHOSPHORYLATION)
MAPK CASCADE
REGULATES GENE EXPRESSION
CELLULAR GROWTH
DIFFERENTIATION
Myc, Fos, Jun PROTEINS (TRANSCRIPTION FACTORS)
PI3K CASCADE
CHANGES PHOSPHORYLATION STATES OF SOME ENZYMES
STIMULATES GLYCOGEN SYNTHESIS
CONTROL OF VESICLE TRAFFICKING
GLUT4 GLUCOSE TRANSPORTER TRANSLOCATED TO CELL SURFACE
RATE OF GLUCOSE TRANSPORT INTO CELL
INSULIN SIGNALING: SHORT SLIDE
PROTEINS THAT BIND TO pY RESIDUES OF IR
Shc
Gab-1
Aps/Cbl Complex
IRS Proteins
PHOSPHORYLATION CASCADES ACTIVATED
MAPK: PHOSPHORYLATES NUCLEAR TRANSCRIPTION
FACTORS (Myc,Fos,Jun) GENE EXPRESSION
PI3K:
STIMULATES GLYCOGEN SYNTHESIS
GLUCOSE TRANSPORT INTO CELL BY STIMULATING
TRANSLOCATION OF GLUT4 TRANSPORTERS
WHAT IS THE LINK BETWEEN OBESITY
AND TYPE II DIABETES?
WHAT CAUSES INSULIN RESISTANCE?
ONE PROPOSAL BY GERALD SHULMAN (2005)
FFAs DIFFUSE INTO MUSCLE CELLS
PRODUCTION OF FATTY ACYL-CoA
ACTIVATION OF PROTEIN KINASE C (PKC)
TRIGGERING OF A SER/THR KINASE CASCADE
PHOSPHORYLATION OF IRS-1
INCREASES SER/THR PHOSPHORYLATION
DECREASES TYR PHOSPHORYLATION BY INSULIN SIGNAL
DECREASE IN TYR PHOS. ACTIVATION OF PI3K
RATE OF FUSION OF GLUT4-VESICLES
GLUCOSE ENTERING CELL
(FATTY ACIDS CAUSE INSULIN RESISTANCE BY DIRECTLY INHIBITING INSULIN-STIMULATED
GLUCOSE TRANSPORT ACTIVITY)
From: Lowell BB, Shulman GI. 2005. “Mitochondrial Dysfunction and Type 2 diabetes”. Science. 307: 384-387.
STUDY QUESTION
• EXPLAIN HOW INCREASED FREE
FATTY ACIDS CAUSES INSULIN
RESISTANCE.